Validation of magnetic resonance elastography plus fibrosis-4 for significant fibrosis in nonalcoholic fatty liver disease.
Kento InadaNobuharu TamakiMasayuki KurosakiSakura KirinoKoji YamashitaYuka HayakawaMayu HiguchiKenta TakauraShun KanekoChiaki MaeyashikiYutaka YasuiKaoru TsuchiyaHiroyuki NakanishiNamiki IzumiPublished in: Journal of gastroenterology and hepatology (2022)
MEFIB is useful for detecting patients with significant fibrosis and could be utilized in a different cohort without changing the threshold of FIB-4, and it may then be used as a two-step screening strategy.
Keyphrases